DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Orticumab
Orticumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Valstybinės Vaistų Kontrolės Tarnybos Prie Lietuvos Respublikos Sveikatos Apsaugos Ministerijos Viršininko Į S a K Y M a S
(INN) for Biological and Biotechnological Substances
Antibody Based Therapy in Coronary Artery Disease and Heart Failure
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
(INN) for Biological and Biotechnological Substances
Strategies to Obtain Diverse and Specific Human Monoclonal
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
An Overview of the Current Status of Engineered Therapeutic Monoclonal Antibodies
(12) Patent Application Publication (10) Pub. No.: US 2017/0173267 A1 Ashmead Et Al
International Nonproprietary Names for Pharmaceutical Substances (INN)
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Top View
Antibody Based Therapy in Coronary Artery Disease and Heart Failure
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(INN) for Biological and Biotechnological Substances
WO 2015/081891 Al
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
WO 2017/189679 Al 02 November 2017 (02.11.2017) W !P O PCT